GLAND.NS · Gland Pharma Limited
India · RS rating 93 · As of 2026-10-14
| Price | 3,052.30 INR |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 82 / 87 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 53 / 58 / 73 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | -13.5% |
| Sales growth Q/Q | +3.3% |
| Distance from 52-week high | +3.1% |
| Market cap (USD) | $5.3B |